JA2131
JA2131 is a small molecular inhibitor of Poly (ADP-ribose) Glycohydrolase (PARG) (IC50=0.4 μM) . JA2131 regulate DNA damage responses, causes replication fork stalling and cancer cell death[1][2].
Product Specifications
CAS Number
6505-99-3
UNSPSC
12352005
Target
Poly (ADP-ribose) Glycohydrolase (PARG)
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ja2131.html
Purity
99.7
Solubility
DMSO : 12.5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(N1C)N(C)C2=C(N=C(SCCN3CCOCC3)N2)C1=S
Molecular Formula
C13H19N5O2S2
Molecular Weight
341.45
References & Citations
[1]Houl JH, et al. Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death. Nat Commun. 2019 Dec 11;10 (1) :5654. |[2]Brosey CA, et al. Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly (ADP-ribose) glycohydrolase (PARG) structures with inhibitors. Prog Biophys Mol Biol. 2021 Aug;163:171-186.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
KLX0216 1x 96 Well
GENLISA™ Rabbit Nuclear Factor Kappa B (NFkB) ELISA
Sign In for Pricing
View Details 
RC205465L4V 200 µL
FANK1 (NM_145235) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details